Assay plates on an automated platform using PromarkerD to test for the early signs of chronic kidney disease in type 2 diabetes patients....

Results from a trial of Proteomics International Laboratories’ PromarkerD blood test for the detection of chronic kidney disease have...

Proteomics International Laboratories has opened a new laboratory in the United States, certified by the State of California, to roll out...

OxiDx, a majority-owned subsidiary of biotech company Proteomics International, has revealed a simple fingerprick test to detect and...

Proteomics International’s game-changing PromarkerEndo diagnostic blood test for endometriosis has passed its latest clinical trials with...

Perth-based Proteomics International has received a $2.16m R&D for costs incurred in the previous financial year on the research of...

Proteomics International Laboratories (ASX: PIQ) has taken a significant new step in its fight against one of the world’s deadliest...

Proteomics International Laboratories (ASX: PIQ) has hired industry veteran Dr James Williams as a non-executive director in a boardroom...

Proteomics International Laboratories (ASX: PIQ) testing using its “PromarkerD” device that employs a simple blood test has shown a high...

Proteomics International Laboratories (ASX: PIQ) has sealed a new deal with medical diagnostics company Eurobio Scientific to distribute...

Proteomics International Laboratories (ASX: PIQ) is escalating its expansion into the European market after appointing Netherlands-based...

Research conducted by Proteomics International Laboratories (ASX: PIQ) and Curtin University has made a crucial discovery in...

ASX-listed Proteomics International (ASX: PIQ) has joined forces with England’s revered Oxford University as the medtech continues to...

Proteomics International Laboratories (ASX: PIQ) will continue important research and development for its diagnostic test products after...

Proteomics International Laboratories’ 66 per cent-owned subsidiary OxiDx has been awarded a European patent for its finger-prick...

Proteomics International Laboratories is showcasing its latest diagnostic milestones for endometriosis and oesophageal cancer in front of...

Proteomics International Laboratories has signed a licence agreement to sell its PromarkerD predictive test for diabetic kidney disease...

Proteomics International Laboratories is nudging closer to commercialising its PromarkerD predictive test for diabetic kidney disease...

Medical technology company Proteomics International’s finances have received a timely $1.85 million tax rebate boost under the Australian...

Proteomics International Laboratories’ share price has hit a seven-month high after a United States federal health agency set a national...